Records / Price observations

Substantially all assets of 23andMe Holding Co. (about 13 million customers' genetic and other personal data, laboratory, brand), Regeneron Pharmaceuticals' bid that won the three-day May 2025 auction (seven bidders, opening bid $52 million) and was later topped

$256 million per bid for substantially all assets of one company (whole-business bundle)

Dated May 2025Source checked 19 Oct 2026Page out of reach at the last check, 21 Oct 2026Basis: docket

In the source's own words
“The Debtors held a three-day auction beginning on May 14, with seven bidders participating and an opening bid of $52 million (Walper Decl. ¶ 13). At the conclusion of the auction, the Special Committee selected Regeneron as the successful bidder, with a bid of $256 million”
Also read from the same source

All 10 records from this source

Substantially all assets of 23andMe Holding Co. (about 13 million customers' genetic and… | AIData.Broker